Cite
Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial.
MLA
Aghili, Mahdi, et al. “Short-Course versus Long-Course Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: Preliminary Results of a Randomized Controlled Trial.” Radiation Oncology Journal, vol. 38, no. 2, June 2020, pp. 119–28. EBSCOhost, https://doi.org/10.3857/roj.2020.00115.
APA
Aghili, M., Khalili, N., Khalili, N., Babaei, M., Farhan, F., Haddad, P., Salarvand, S., Keshvari, A., Fazeli, M. S., Mohammadi, N., & Ghalehtaki, R. (2020). Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial. Radiation Oncology Journal, 38(2), 119–128. https://doi.org/10.3857/roj.2020.00115
Chicago
Aghili, Mahdi, Nastaran Khalili, Neda Khalili, Mohammad Babaei, Farshid Farhan, Peiman Haddad, Samaneh Salarvand, et al. 2020. “Short-Course versus Long-Course Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: Preliminary Results of a Randomized Controlled Trial.” Radiation Oncology Journal 38 (2): 119–28. doi:10.3857/roj.2020.00115.